Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

MOREPEN LABS Gains 5%; BSE HEALTHCARE Index Up 0.5%
Tue, 6 Oct 10:55

MOREPEN LABS Gains 5%; BSE HEALTHCARE Index Up 0.5%Image source: peterschreiber.media/www.istockphoto.com

MOREPEN LABS share price has zoomed 5% and is presently trading at Rs 142.4.

Meanwhile, the BSE HEALTHCARE index is at 49,558.3 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are LAURUS LABS (up 2.4%) and SUN PHARMA ADV. RES. (up 2.3%).

J.B.Chemicals (down 3.7%) and METROPOLIS HEALTHCARE (down 2.3%) are among the top losers today.

Over the last one year, MOREPEN LABS has moved up from Rs 48.8 to Rs 142.4, registering a gain of Rs 93.6 (up 191.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 43,982.5 to 49,558.3, registering a gain of 12.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 133.0%), Divis Laboratories (up 60.2%) and Aurobindo Pharma (up 54.4%).

Festive Offer: We're Giving You Savings of Over Rs 17,000

What About the Benchmark Indices?

The BSE Sensex is at 72,747.9 (up 0.5%).

The top gainers among the BSE Sensex today are Kotak Bank (up 3.5%) and Indusind Bank (up 2.0%). The most traded stocks in the BSE Sensex are ITC and Kotak Bank.

In the meantime, NSE Nifty is at 22,670.4 (up 0.5%). Trent and Kotak Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved down from 81,790.1 to 72,747.9, registering a loss of 9,042.3 points (down 11.1%).

MOREPEN LABS Financial Update...

MOREPEN LABS net profit grew 394.0% YoY to Rs 563 million for the quarter ended June 2026, compared to a profit of Rs 114 million a year ago. Net sales rose 34.1% to Rs 5,701 million during the period as against Rs 4,252 million in April-June 2025.

For the year ended March 2026, MOREPEN LABS reported 19.0% decrease in net profit to Rs 956 million compared to net profit of Rs 1,180 million during FY25. Revenue of the company fell 0.3% to Rs 18,057 million during FY26.

The current Price to earnings ratio of MOREPEN LABS, based on rolling 12 month earnings, stands at 55.5.


Equitymaster requests your view! Post a comment on "MOREPEN LABS Gains 5%; BSE HEALTHCARE Index Up 0.5%". Click here!